OSAJIN
| 中文名稱 | OSAJIN |
|---|---|
| 中文同義詞 | 奧沙京;化合物 Osajin |
| 英文名稱 | OSAJIN |
| 英文同義詞 | OSAJIN;5-Hydroxy-3-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methyl-2-butenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one;5-hydroxy-3-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one;OSAJIN(RG);5-hydroxy-3-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methyl-2-butenyl)-4H,8H-pyrano[2,3-f]chromen-4-one;4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one,5-hydroxy-3-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methyl-2-buten-1-yl)-;NSC 21565;CID 95168 |
| CAS號 | 482-53-1 |
| 分子式 | C25H24O5 |
| 分子量 | 404.46 |
| EINECS號 | |
| 相關(guān)類別 | 標(biāo)準(zhǔn)品;植物提取物;標(biāo)準(zhǔn)品 -對照藥材;黃酮;對照品 |
| Mol文件 | 482-53-1.mol |
| 結(jié)構(gòu)式 | ![]() |
OSAJIN 性質(zhì)
| 熔點(diǎn) | 189° (uncorr), 193° (corr) |
|---|---|
| 沸點(diǎn) | 632.3±55.0 °C(Predicted) |
| 密度 | 1.258±0.06 g/cm3(Predicted) |
| 儲存條件 | -20°C |
| 溶解度 | 溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。 |
| 形態(tài) | 粉末 |
| 酸度系數(shù)(pKa) | 7.00±0.40(Predicted) |
| 顏色 | 粘黃色 |
| 主要應(yīng)用 | 代謝組學(xué) 維生素、營養(yǎng)保健品和天然產(chǎn)品 |
| 化妝品成分功效 | 抗氧化劑 |
| InChI | 1S/C25H24O5/c1-14(2)5-10-17-21(27)20-22(28)19(15-6-8-16(26)9-7-15)13-29-24(20)18-11-12-25(3,4)30-23(17)18/h5-9,11-13,26-27H,10H2,1-4H3 |
| InChIKey | DCTLJGWMHPGCOS-UHFFFAOYSA-N |
| SMILES | C\C(C)=C\Cc1c(O)c2C(=O)C(=COc2c3C=CC(C)(C)Oc13)c4ccc(O)cc4 |
Apoptosis
Osajin significantly decreases the viability of human NPC cells (TW076, CG1 and TW04 cells) in a dose-dependent manner. Osajin induces apoptosis in human NPC cells through multiple apoptotic pathways, including the extrinsic death receptor pathway, and intrinsic pathways relying on mitochondria and endoplasmic reticulum stress. Osajin exhibits growth inhibitory activity on six human cancer cell lines, including kidney, lung, prostate, breast, melanoma and colon cancer cells.
Osajin and pomiferin attenuates the myocardial dysfunction provoked by ischemia reperfusion. This is confirmed by an increase in both antioxidant enzyme values and total antioxidant activity. The cardioprotection provided by osajin and pomiferin treatment results from the suppression of oxidative stress and this correlates with improved ventricular function.
安全信息
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-N3125 | Osajin | 482-53-1 | 1 mg | 3100元 |
